|
UWCCC Grand Rounds: "Classification of the collagen ECM in normal human tissue as a biomarker for future breast cancer incidence" |
11/28/2018 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: "Exploiting unique prostate cancer phenotypes to improve detection and treatment" |
12/05/2018 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: Cancer Prevention Agent Development |
12/12/2018 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: Early treatment for metastatic prostate cancer: What have we learned so far? |
12/19/2018 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: "Understanding the Prostate Cancer Genome: From Biomarker Discovery to Clinical Application" |
01/09/2019 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: "Frontiers in Physical Activity and Cancer Survivorship" |
01/16/2019 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: "Towards CAR T cell therapy of myeloid malignancies" |
01/23/2019 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: "Highlights from the annual ASH conference" |
02/13/2019 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds: "Expanding Precision Guided Treatment Strategies for Patients with Cancer" |
02/20/2019 - 8:00am to 9:00am CST |
|
UWCCC Grand Rounds:‘NextGen’ Cancer Treatments will Feature ‘NextEpigen’ Epigenetic Approaches |
02/27/2019 - 8:00am to 9:00am CST |
Facebook
Twitter
LinkedIn
Forward